Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

38%

3 trials in Phase 3/4

Results Transparency

43%

3 of 7 completed trials have results

Key Signals

1 recruiting3 with results

Enrollment Performance

Analytics

N/A
4(57.1%)
Phase 4
2(28.6%)
Phase 3
1(14.3%)
7Total
N/A(4)
Phase 4(2)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)